COLCHICINE
Product Description
Indena S.P.A
-
IT
-
2015On CPHI since
-
5Certificates
-
500 - 999Employees
Company types
Primary activities
Indena S.P.A
-
IT
-
2015On CPHI since
-
5Certificates
-
500 - 999Employees
Company types
Primary activities
More Products from Indena S.P.A (41)
-
Product Chamomile Extract
Indena SpA offers a wide range of pharmaceutical products which includes chamomile extract. Botanical origin: matricaria recutita l. flowering head, leave. Biological activity: spasmolytic. Contact us for more information. -
Product Colchicine Micronized
Colchicine micronized. Botanical origin: gloriosa superba l. seed. Biological activity: antigout. -
Product BOLDINE
PURE MOLECULE ISOLATED OR DERIVED FROM PLANTS -
Product Cabazitaxel
Proprietary crystalline form; semisynthetic taxane derivative. Botanical origin: taxus baccata L. twig and leaf. Biological activity: anti-mitotic, anticancer. -
Product CABAZITAXEL
Antimitotic / Anticancer -
Product CBD
Natural, from Cannabis sativa L. -
Product COLCHICOSIDE
Chemical intermediate -
Product Thiocolchicoside B
Indena SpA offers a wide range of pharmaceutical products which includes thiocolchicoside b. Botanical origin: gloriosa superba l. seed. Biological activity: muscle relaxant. Contact us for more information. -
Product Valeroselect®
Indena SpA offers a wide range of pharmaceutical products which includes valeroselect®. Botanical origin: valeriana officinalis l. rhizome and root. Biological activity: sedative. Contact us for more information. -
Product Cannabidiol (from hemp)
Natural cannabinoid from hemp -
Product Colchicine Ph. Eur.
Colchicine ph. eur. Botanical origin: gloriosa superba l. seed. Biological activity: antigout. -
Product Colchicine Usp
Colchicine usp. Botanical origin: gloriosa superba l. seed. Biological activity: antigout.
Indena S.P.A resources (3)
-
Video From the Rainforest to the Clinic. Turning a High-Potency Rare Natural Product Into an Anticancer API
Natural products can be characterized by complex structure, limited availability, and exceptional potency, whose combination makes it challenging their development as API. Success requires integration of expertise in different areas, including the construction of a sustainable supply chain for the starting biomass, the capacity to manipulate high-potency products in a GMP environment, and the versatility to strategically complement isolation with semi-synthesis, total synthesis and biotechnology. In this context, mutual thrust between the service provider company and the drug candidate owner is critical, and the successful development of the anticancer drug tigilanol tiglate will give the opportunity to address these issues. -
Whitepaper CDMO services
We have a unique expertise in developing and manufacturing HPAPIs. The company is equipped with kilolabs (for clinical and small commercial batches) and large industrial suite for HPAPIs with an OEL>20 ng/m3.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance